13083685 · Active · incorporated 5 years, 8 months ago · Oxford
Biotech B2B Drug Discovery Healthcare Platform Series B+
Developing novel immuno-oncology therapeutics using a proprietary platform technology to target cancer cells.
https://www.accessiontherapeutics.com/
Accession Therapeutics Limited is a private limited company registered at Companies House under number 13083685, incorporated on 15 December 2020, with a registered office in Oxford. Its current status on the register is active. Its filed nature of business is research and experimental development on biotechnology (SIC 72110). Sonde has indexed 49 filings for this company, including 6 funding rounds. Its most recent round closed in July 2026, raising £14.2m.
| Round | Closed | Raised | Price per share |
|---|---|---|---|
| Round 6 | Jul 2026 | £14.2m | £20.00 |
| Round 5 | Jul 2025 | £11.3m | £43.00 |
| Round 4 | Sep 2024 | £5.7m | £43.00 |
| Round 3 | Nov 2023 | £12.7m | £43.00 |
| Round 2 | Sep 2022 | £8.4m | £43.00 |
| Round 1 | Jun 2021 | £8.8m | £25.00 |
Showing the 11 most recent of 49 filings.
See the complete cap table with every shareholder, founder tags, dilution across 19 share allotments, round-by-round fundraising history, and the full filing timeline — parsed from official Companies House documents.
Create a free account Sign inFree accounts open 3 companies in full detail — no card required.